FFA
CAPR icon

Farther Finance Advisors’s Capricor Therapeutics CAPR Stock Holding History

Farther Finance Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.2K Buy
338
+302
+839% +$3.35K ﹤0.01% 5216
2026
Q2 		$867 Hold
36
– – ﹤0.01% 5409
2026
Q1 		$1.08K Sell
36
-3
-8% -$80 ﹤0.01% 5089
2025
Q4 		$1.13K Sell
39
-3,846
-99% -$50.2K ﹤0.01% 4881
2025
Q3 		$28K Buy
+3,885
New +$28.6K ﹤0.01% 2810

Other funds holding CAPR

GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Farther Finance Advisors's CAPR Position: Q3 2026 in Review

Farther Finance Advisors increased its Capricor Therapeutics (CAPR) stake by 839% in Q3 2026, buying an estimated $3.35K and bringing the position to 338 shares worth $3.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5216.

Farther Finance Advisors first reported a position in CAPR in Q3 2025 and has held it in 5 quarters since. The position peaked at $28K in Q3 2025. 4 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Farther Finance Advisors held 338 shares of Capricor Therapeutics worth $3.2K as of Q3 2026.
  • Farther Finance Advisors bought 302 Capricor Therapeutics shares in Q3 2026, an estimated $3.35K.
  • Capricor Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5216 holding.
  • Farther Finance Advisors first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Farther Finance Advisors's Capricor Therapeutics position peaked at $28K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.